Legacy Pharmaceuticals International is dedicated to customer-focused contract manufacturing of large and small volume products and the ownership and licensing of small volume but difficult to produce niche drugs. Products produced by Legacy meet the needs of patients in over 70 countries world-wide.

Formed in 2007, with the acquisition from Valeant Pharmaceuticals International of two world-class manufacturing sites and selected brands, Legacy is ideally positioned to capitalize upon the changing manufacturing trends in today's evolving pharmaceutical marketplace. 


We would like to inform you that our offices in Birsfelden remain closed from December 22nd, 2014 to January 5th, 2015.

We would like to thank you for your cooperation, your trust and your confidence as our partner.

We wish you, your family and friends a Happy and Merry Christmas and a good start and success for the New Year.